Ceftaroline
Ceftaroline is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Acute bacterial skin and skin structure infections (ABSSSIs)
- Due to susceptible organisms: S. aureus(including MRSA), S. pyogenes, S. agalactiae, E.coli, K. pneumoniae, K. oxytoca.
- Community acquired pneumonia (including cases caused by PCN-resistant S. pneumoniae)
- Due to susceptible organisms: S. pneumoniae (including cases with bacteremia), MSSA, H. influenzae, K. pneumoniae, E. coli
- Due to susceptible organisms: S. pneumoniae (including cases with bacteremia), MSSA, H. influenzae, K. pneumoniae, E. coli
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- MRSA infections not listed above
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Acute bacterial skin and skin structure infections (ABSSSIs)
- Due to susceptible organisms: S. aureus(including MRSA), S. pyogenes, S. agalactiae, E.coli, K. pneumoniae, K. oxytoca.
- Community acquired pneumonia (including cases caused by PCN-resistant S. pneumoniae)
- Due to susceptible organisms: S. pneumoniae (including cases with bacteremia), MSSA, H. influenzae, K. pneumoniae, E. coli
- Due to susceptible organisms: S. pneumoniae (including cases with bacteremia), MSSA, H. influenzae, K. pneumoniae, E. coli
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- MRSA infections not listed above
There's more to see -- the rest of this entry is available only to subscribers.
© 2000–2022 Unbound Medicine, Inc. All rights reserved